Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dodonaea viscosa hydroethanolic extract is a plant-based preparation obtained by macerating the leaves (and sometimes other aerial parts) of *Dodonaea viscosa* in a water-ethanol solution, typically around 70% ethanol[3][4]. This extract contains a range of bioactive phytochemicals, including flavonoids (such as isorhamnetin, quercetin, kaempferol, and apigenin), polyphenols, saponins, triterpenes, coumarins, tannins, and phenols[3][2][4]. The hydroethanolic extract demonstrates multiple pharmacological activities, notably **cytotoxicity and antiproliferative effects** against various cancer cell lines (including colorectal, breast, lung, and ovarian cancer), **anti-inflammatory**, **antimicrobial**, and **antioxidant** actions[3][4][5][1]. Mechanistically, antitumor effects are associated with induction of mitochondrial-dependent apoptosis (upregulation of caspase 3, p53), cell cycle arrest, and loss of mitochondrial membrane potential in tumor cells[3][4]. It is also traditionally used for disorders such as rheumatism, skin infections, gastrointestinal ailments, and wound healing[1][2][6]. It is not a registered pharmaceutical; uses are predominantly medicinal, ethnobotanical, or experimental.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dodonaea viscosa hydroethanolic extract.